CClinicalTrials.gg
CompletedNCT02774668Updated May 4, 2025Results posted

A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults

An interventional study of "Grab-and-Go" meal plan and "Jump-Start" meal plan in Metabolic Syndrome, sponsored by University of Missouri-Columbia. Completed at 1 site in United States. Open to participants aged 30 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-04.

Sponsored by University of Missouri-Columbia · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
30 Years to 55 Years
Sex
All
01

Study summary

The present study is designed to examine the effect of changes in body weight and related parameters associated with a commercially-available, low-carbohydrate diet plan. A parameter proposed to be studied here is the impact of fructose restriction and weight loss on serum uric acid concentrations and arterial stiffness.

Read the detailed description

It is well know that consumption of a calorically-restricted diet helps people lose weight. Such a diet with low carbohydrate lowers the serum uric acid concentration which is a factor associated with obesity and also represents a particular metabolic risk in women compared to men. The present weight loss study will determine whether women benefit more than men to short-term weight loss occurring during restriction of simple sugars.

Specifically, this study is designed to cause weight loss acutely through consumption of a diet that is restricted in calorie and simple sugars. Both men and women will be studied and their results compared to determine whether women benefit more with respect to arterial stiffness. Upon finishing the four-week diet intervention, body weight and blood lipids will be assessed two and four weeks later to compare the longer term effect on blood pressure.

02

Conditions studied

  • Metabolic Syndrome

Keywords

  • gender
  • arterial stiffness
  • blood pressure
  • weight loss
  • uric acid
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 850 are open to participants now.

This study's enrollment of 20 is below the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

University of Missouri-Columbia is the lead sponsor of 357 studies on the registry; 70 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 28 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Men and premenopausal women
  2. 30-55 years of age
  3. Sedentary lifestyle, defined as less than three sessions of activity per week, or sessions less than 20 minutes per occasion, or less than 5000 steps per day
  4. Must be able to speak, read, and write English (due to the small sample size and pilot nature of this study)
  5. Overweight/obese subjects with BMI 27.0 - 40.0 kg/m2 and any one of the following characteristics of the metabolic syndrome:

A. Serum HDL cholesterol \<40 mg/dL (1 mmol/L) in men and \<50 mg/dL (1.3 mmol/L) in women B. Blood pressure ≥130/85 mmHg C. Fasting plasma glucose ≥100 mg/dL (5.6 mmol/L) D. Waist circumference in men of >102 cm (40 in) and in women of >88 cm (35 in) E. Serum triglycerides (TG) ≥150 mg/dL (1.7 mmol/L).

Exclusion criteria

Exclusion Criteria:

  1. Abnormal thyroid function or known liver disease
  2. Diabetes or fasting glucose ≥ 125 mg/dL
  3. Use of medications that interfere with protein, carbohydrate or lipid metabolism (e.g., fish oil capsules)
  4. Occasional or regular tobacco use
  5. History of gout
  6. Uncontrolled hypertension
  7. Pregnant or peri-menopausal
  8. Vegetarian food restrictions (the diets consumed contain some meat, eggs and dairy)
  9. Alcohol intake: females > 70 g/wk, males >140 g/wk
  10. Moderate or vigorous-intensity physical activity, defined as more than 150 minutes per week of moderate-intensity, or 75 minutes a week of vigorous-intensity aerobic physical activity, or an equivalent combination of both.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    "Grab-and-Go" meal plan

    The intervention of this arm is to use a "Grab-and-Go" meal plan. This meal plan provides Atkins shakes and bars for breakfast, lunch, and snacks for 2 weeks. For dinner the subject is given a freshly-prepared meal. Upon finishing the 2-week provided food phase, the subject will consume a self-prepared meal of similar nutrient composition at home for another 2 weeks. For the next four weeks while he/she is still enrolled in the study, he/she will have his/her options for food choices which are not controlled for the study.

    Other: "Grab-and-Go" meal plan

  • Active comparator
    "Jump-Start" meal plan

    The intervention of this arm is to use a "Jump Start" meal plan. This meal plan provides Atkins frozen meals at breakfast, lunch and dinner for 2 weeks and these meals are supplemented with fresh salads and vegetables. Upon finishing the 2-week provided food phase, the subject will consume a self-prepared meal of similar nutrient composition at home for another 2 weeks. For the next four weeks while he/she is still enrolled in the study, he/she will have his/her options for food choices which are not controlled for the study.

    Other: "Jump-Start" meal plan

Interventions

  • Other"Grab-and-Go" meal plan

    The "Grab-and-Go" meal plan will provide Atkins shakes and bars for breakfast, lunch, and snacks. For dinner, the participant will receive a freshly-prepared meal. There will be no difference in terms of calories or nutrient composition between "Grab-and-Go" meal plan versus "Jump-Start" meal plan. The amount of weight loss caused by these two meal plans is not expected to differ.

  • Other"Jump-Start" meal plan

    The "Jump-Start" plan will provide Atkins frozen meals at breakfast, lunch and dinner and these meals will be supplemented with fresh salads and vegetables. There will be no difference in terms of calories or nutrient composition between "Grab-and-Go" meal plan versus "Jump-Start" meal plan. The amount of weight loss caused by these two meal plans is not expected to differ.

06

What researchers measure

Primary outcomes

  1. Weight Loss Between Baseline and 4 Weeks After Completion of Dietary Intervention

    For statistical analysis, the body weight is measured at baseline and after 4 weeks after consumption of a calorie-restricted, low-carbohydrate diet.

    Time frame: Change of body weight over 4 weeks of dietary intervention

Secondary outcomes

  1. Arterial Stiffness Changes Between Baseline and 4 Weeks

    Pulse wave velocity, a non-invasive indicator of arterial stiffness will be assessed at the baseline testing and 4 weeks after the start of the dietary intervention.

    Time frame: Arterial stiffness will be measured at baseline and 4 weeks

  2. Plasma Uric Acid Level Between Baseline and 4 Weeks.

    A fasting blood sample will be collected at baseline, 4 weeks after the start of the dietary intervention to measure plasma uric acid level.

    Time frame: Plasma uric acid level will be measured at baseline and 4 weeks

  3. Change in Food Craving Questionnaire (FCI-II-State) at Baseline and 4 Weeks

    Food craving questionnaire (FCI-II-State) will be administrated at baseline visit and the end of 4-week after dietary change. Cravings are assessed from 0 (no cravings: "Not at all") to 5 (high cravings: "Extremely/Always") for each of the five subscales measures including high-fat foods, sweets, carbohydrates/starches, fast-food fats, and fruits/vegetables. In addition, the scores for each of the subscales were averaged to produce a total cravings measure (also assessed from 0-5).

    Time frame: Questionnaires about food cravings will be administrated at baseline visit and 4 weeks after the start of the meal plan

07

Results

Posted Mar 30, 2023
Limitations and caveats
Limitations are as follows. The loss of weight with low-CHO diet is being assessed over a short period of time. The study has a small sample size and also, it is unknown if these effects would persist with a longer study duration.

Participant flow

Subjects were recruited in the local Columbia, MO area from April 2016 through August 2016

Participant flow — Overall Study
Milestone"Grab-and-Go" Meal Plan"Jump-Start" Meal Plan
Started1010
Completed1010
Not completed00

Outcome measures

PrimaryWeight Loss Between Baseline and 4 Weeks After Completion of Dietary Intervention

For statistical analysis, the body weight is measured at baseline and after 4 weeks after consumption of a calorie-restricted, low-carbohydrate diet.

Time frame:
Change of body weight over 4 weeks of dietary intervention
Reported as:
Mean · kg
Weight Loss Between Baseline and 4 Weeks After Completion of Dietary Intervention
kg"Grab-and-Go" Meal Plan"Jump-Start" Meal Plan
Weight Loss Between Baseline and 4 Weeks After Completion of Dietary Intervention5.5 ± 1.65.9 ± 2.6
SecondaryArterial Stiffness Changes Between Baseline and 4 Weeks

Pulse wave velocity, a non-invasive indicator of arterial stiffness will be assessed at the baseline testing and 4 weeks after the start of the dietary intervention.

Time frame:
Arterial stiffness will be measured at baseline and 4 weeks
Reported as:
Mean · m/s
Arterial Stiffness Changes Between Baseline and 4 Weeks
m/s"Grab-and-Go" Meal Plan"Jump-Start" Meal Plan
Arterial Stiffness Changes Between Baseline and 4 Weeks-0.4 ± 0.8-0.5 ± 0.7
SecondaryPlasma Uric Acid Level Between Baseline and 4 Weeks.

A fasting blood sample will be collected at baseline, 4 weeks after the start of the dietary intervention to measure plasma uric acid level.

Time frame:
Plasma uric acid level will be measured at baseline and 4 weeks
Reported as:
Mean · mg/dL
Plasma Uric Acid Level Between Baseline and 4 Weeks.
mg/dL"Grab-and-Go" Meal Plan"Jump-Start" Meal Plan
Plasma Uric Acid Level Between Baseline and 4 Weeks.0.5 ± 1.40.04 ± 1.2
SecondaryChange in Food Craving Questionnaire (FCI-II-State) at Baseline and 4 Weeks

Food craving questionnaire (FCI-II-State) will be administrated at baseline visit and the end of 4-week after dietary change. Cravings are assessed from 0 (no cravings: "Not at all") to 5 (high cravings: "Extremely/Always") for each of the five subscales measures including high-fat foods, sweets, carbohydrates/starches, fast-food fats, and fruits/vegetables. In addition, the scores for each of the subscales were averaged to produce a total cravings measure (also assessed from 0-5).

Time frame:
Questionnaires about food cravings will be administrated at baseline visit and 4 weeks after the start of the meal plan
Reported as:
Mean · score on a scale
Change in Food Craving Questionnaire (FCI-II-State) at Baseline and 4 Weeks
score on a scale"Grab-and-Go" Meal Plan"Jump-Start" Meal Plan
Change in Food Craving Questionnaire (FCI-II-State) at Baseline and 4 Weeks-0.4 ± 0.6-0.3 ± 0.5

Adverse events

Collected over Adverse event data were collected from the time the subjects entered baseline testing, during their consumption of the diets, and through the follow-up testing. Because the diets were whole foods, commonly consumed we did not expect many adverse events.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
"Grab-and-Go" Meal Plan0/10 (0%)0/10 (0%)0/10 (0%)
"Jump-Start" Meal Plan0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)"Grab-and-Go" Meal Plan"Jump-Start" Meal PlanTotal
<=18 years000
Between 18 and 65 years101020
>=65 years000
Age, Continuous
Age, Continuous(years)"Grab-and-Go" Meal Plan"Jump-Start" Meal PlanTotal
Mean41.2 ± 7.939.2 ± 9.040.2 ± 8.3
Sex: Female, Male
Sex: Female, Male(Participants)"Grab-and-Go" Meal Plan"Jump-Start" Meal PlanTotal
Female5510
Male5510
Race (NIH/OMB)
Race (NIH/OMB)(Participants)"Grab-and-Go" Meal Plan"Jump-Start" Meal PlanTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American112
White9918
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)"Grab-and-Go" Meal Plan"Jump-Start" Meal PlanTotal
United States101020
08

Study locations

1 site
  • University of Missouri
    Columbia, Missouri 65212, United States
09

References and documents

Publications

  • Syed-Abdul MM, Hu Q, Jacome-Sosa M, Padilla J, Manrique-Acevedo C, Heimowitz C, Parks EJ. Effect of carbohydrate restriction-induced weight loss on aortic pulse wave velocity in overweight men and women. Appl Physiol Nutr Metab. 2018 Dec;43(12):1247-1256. doi: 10.1139/apnm-2018-0113. Epub 2018 May 10. PubMed 29746789 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 18, 2016
  • Informed consent form · Apr 13, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02774668
Lead sponsor
University of Missouri-Columbia
Collaborators
Robert C. Atkins Foundation
Responsible party
Elizabeth Jane Parks (Professor, Nutrition & Exercise Physiology-MED, University of Missouri-Columbia) — Principal investigator
First posted
May 17, 2016
Start date
May 2016
Primary completion
Apr 2017
Completion
Apr 2017
Results posted
Mar 30, 2023
Last update
May 4, 2025

Study contacts

Qiong Hu, PhD
principal investigator · University of Missouri-Columbia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion